Modern diagnostic methods allow growers to detect pathogens earlier and identify disease pressure with far greater precision than traditional testing methods.

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...

UW Medicine is boosting its measles testing as the nationwide outbreak continues — and as Seattle prepares to welcome ...

Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...

Project demonstrates that a multiplex tNGS assay can function as a reliable and informative diagnostic tool.

Politicians aren’t the best judges of the merits of scientific research. Read more at straitstimes.com. Read more at ...

All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, ...

Discover the principles behind Countable PCR, how it compares with established molecular quantification methods, and what direct RNA counting could mean for research and clinical applications.

An identical twin commits a crime and leaves their DNA at the scene. Can DNA testing reveal which twin is the culprit? This question reportedly came up in a case in France last month, in which the ...

In a French criminal trial, conventional DNA analysis couldn’t distinguish between twin brothers, but emerging scientific ...

A genetic variant called IMP-18, common in Costa Rica and other Latin American countries, was not detected by commercial systems.

The company received $441,437 from the foundation to miniaturize its molecular point-of-care test for HIV viral load.